NCT05588635View on ClinicalTrials.gov

Association Between Live Birth Rate and Serum Progesterone During Hormonal Replacement Therapy

CompletedOBSERVATIONAL
Enrollment

168

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

March 1, 2021

Study Completion Date

March 1, 2021

Conditions
Ovarian Hyperstimulation SyndromeFrozen-thawed Embryo Transfers
Interventions
OTHER

Identification of predictive factors

Evaluation of the following variables : mother age (years), father age (years), serum progesterone (ng/ml), mother body mass index (kg/m2), serum Antimüllerian hormone (AMH) (ng/ml), infertility etiology (yes/no): 4 categories: idiopathic etiology, mixed origin infertility, male infertility, female infertility; smoker status among mothers (yes/no).

Trial Locations (1)

57085

CHR Metz-Thionville/Hopital de Mercy, Metz

All Listed Sponsors
lead

Centre Hospitalier Régional Metz-Thionville

OTHER

NCT05588635 - Association Between Live Birth Rate and Serum Progesterone During Hormonal Replacement Therapy | Biotech Hunter | Biotech Hunter